Susquehanna International Group’s OptiNose OPTN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-2,847
Closed -$79K 13215
2022
Q4
$79K Sell
2,847
-180
-6% -$6.84K ﹤0.01% 11134
2022
Q3
$166K Buy
+3,027
New +$166K ﹤0.01% 11106
2022
Q2
Sell
-8,513
Closed -$315K 13641
2022
Q1
$315K Buy
+8,513
New +$304K ﹤0.01% 10155

Susquehanna International Group's OPTN Position: Q2 2025 in Review

Susquehanna International Group sold out of OptiNose (OPTN) in Q2 2025, closing a stake of 67,547 shares — an estimated $619K sold.

Susquehanna International Group first reported a position in OPTN in Q2 2019 and held it in 17 quarters. The position peaked at $619K in Q1 2025. 0 funds tracked by Wall St. Rank hold OPTN as of Q2 2025.

  • Susquehanna International Group reported no remaining OptiNose position as of Q2 2025 after selling out during the quarter.
  • Susquehanna International Group sold 67,547 OptiNose shares in Q2 2025, an estimated $619K.
  • Susquehanna International Group first reported a position in OptiNose in Q2 2019 and held it in 17 quarters.
  • Susquehanna International Group's OptiNose position peaked at $619K in Q1 2025.
  • 0 funds tracked by Wall St. Rank held OptiNose as of Q2 2025.

Based on Susquehanna International Group's 13F filing for Q2 2025, filed 14 Aug 2025.